BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Tajima K, Tominaga S. Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection. Jpn J Cancer Res 2001;92:488-93. [PMID: 11376556 DOI: 10.1111/j.1349-7006.2001.tb01120.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 2006;19:449-90. [DOI: 10.1128/cmr.00054-05] [Reference Citation Analysis]
2 Meisel P, Krause T, Cascorbi I, Schroeder W, Herrmann F, John U, Kocher T. Gender and smoking-related risk reduction of periodontal disease with variant myeloperoxidase alleles. Genes Immun 2002;3:102-6. [DOI: 10.1038/sj.gene.6363840] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
3 Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19:449-490. [PMID: 16847081 DOI: 10.1128/cmr.00054-05] [Cited by in Crossref: 1188] [Cited by in F6Publishing: 628] [Article Influence: 74.3] [Reference Citation Analysis]
4 Yilmaz &, Dursun H, Gürsan N, Pirim İ, Yılmaz A, Okcu N. Effects of the myeloperoxidase 463 gene polymorphisms on development of atrophy in H pylori infected or noninfected gastroduodenal disease. World J Gastroenterol 2007; 13(8): 1243-1246 [PMID: 17451207 DOI: 10.3748/wjg.v13.i8.1243] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Reynolds WF, Patel K, Pianko S, Blatt LM, Nicholas JJ, McHutchison JG. A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection. Genes Immun. 2002;3:345-349. [PMID: 12209361 DOI: 10.1038/sj.gene.6363880] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
6 Ito LS, Oba SM, Hamajima N, Marie SK, Uno M, Shinjo SK, Kino A, Lavilla F, Inoue M, Tajima K, Tominaga S. Helicobacter pylori seropositivity among 963 Japanese Brazilians according to sex, age, generation, and lifestyle factors. Jpn J Cancer Res 2001;92:1150-6. [PMID: 11714438 DOI: 10.1111/j.1349-7006.2001.tb02134.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
7 Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 2006;19:449-90. [DOI: 10.1128/cmr.00054-05] [Reference Citation Analysis]
8 Park JH, Park JM, Kim EJ, Cha SI, Lee EB, Kim CH, Kam S, Jung TH, Yong Park J. Myeloperoxidase −463G>A polymorphism and risk of primary lung cancer in a Korean population. Cancer Detection and Prevention 2006;30:257-61. [DOI: 10.1016/j.cdp.2006.04.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
9 Hoy A, Leininger-muller B, Kutter D, Siest G, Visvikis S. Growing Significance of Myeloperoxidase in Non-infectious Diseases. Clinical Chemistry and Laboratory Medicine 2002;40. [DOI: 10.1515/cclm.2002.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
10 He B, Zhang Y, Pan Y, Xu Y, Gu L, Chen L, Wang S. Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies. Mutagenesis 2011;26:637-42. [PMID: 21653279 DOI: 10.1093/mutage/ger025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
11 Hamajima N, Katsuda N, Matsuo K, Saito T, Hirose K, Inoue M, Zaki TT, Tajima K, Tominaga S. High anti-Helicobacter pylori antibody seropositivity associated with the combination of IL-8-251TT and IL-10-819TT genotypes. Helicobacter. 2003;8:105-110. [PMID: 12662377 DOI: 10.1046/j.1523-5378.2003.00130.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
12 Panic N, Mastrostefano E, Leoncini E, Persiani R, Arzani D, Amore R, Ricci R, Sicoli F, Sioletic S, Bulajic M, D' Ugo D, Ricciardi W, Boccia S. Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients. Mol Biol Rep 2014;41:3637-50. [PMID: 24526578 DOI: 10.1007/s11033-014-3228-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
13 Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med 2005;7:463-78. [PMID: 16170238 DOI: 10.1097/01.gim.0000177530.55043.c1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
14 Debabrata K, Prasanta B, Vineet N, Anshul G, Arindam S, Satadal D. Aggressive periodontitis: An appraisal of systemic effects on its etiology-genetic aspect. J Indian Soc Periodontol 2015;19:169-73. [PMID: 26015667 DOI: 10.4103/0972-124X.148647] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Dally H, Gassner K, Jäger B, Schmezer P, Spiegelhalder B, Edler L, Drings P, Dienemann H, Schulz V, Kayser K, Bartsch H, Risch A. Myeloperoxidase (MPO) genotype and lung cancer histologic types: The MPO −463 A allele is associated with reduced risk for small cell lung cancer in smokers: Myeloperoxidase and Lung Cancer Risk. Int J Cancer 2002;102:530-5. [DOI: 10.1002/ijc.10756] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
16 Valadez-Cosmes P, Raftopoulou S, Mihalic ZN, Marsche G, Kargl J. Myeloperoxidase: Growing importance in cancer pathogenesis and potential drug target. Pharmacol Ther 2021;:108052. [PMID: 34890688 DOI: 10.1016/j.pharmthera.2021.108052] [Reference Citation Analysis]
17 Hamajima N, Hishida A. Genetic traits for the persistence of Helicobacter pylori infection. Per Med 2010;7:249-62. [PMID: 29776221 DOI: 10.2217/pme.10.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
18 Vanhamme L, Zouaoui Boudjeltia K, Van Antwerpen P, Delporte C. The other myeloperoxidase: Emerging functions. Arch Biochem Biophys 2018;649:1-14. [PMID: 29614255 DOI: 10.1016/j.abb.2018.03.037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
19 Reynolds WF, Stegeman CA, Cohen Tervaert JW. −463 G/A Myeloperoxidase Promoter Polymorphism Is Associated with Clinical Manifestations and the Course of Disease in MPO-ANCA-Associated Vasculitis. Clinical Immunology 2002;103:154-60. [DOI: 10.1006/clim.2002.5206] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
20 Meisel P. Cancer, genes and gender. Carcinogenesis 2002;23:1087-8. [DOI: 10.1093/carcin/23.6.1087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
21 Hansson M, Olsson I, Nauseef WM. Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 2006;445:214-24. [PMID: 16183032 DOI: 10.1016/j.abb.2005.08.009] [Cited by in Crossref: 154] [Cited by in F6Publishing: 141] [Article Influence: 9.1] [Reference Citation Analysis]
22 Hamajima N, Naito M, Kondo T, Goto Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci. 2006;97:1129-1138. [PMID: 16879717 DOI: 10.1111/j.1349-7006.2006.00290.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
23 Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 2006;19:449-90. [DOI: 10.1128/cmr.00054-05] [Reference Citation Analysis]